Borgen PI - Search Results

1

Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.

Calvano JE, Rush EB, Tan LK, Rosen PP, Borgen PI, Van Zee KJ. Calvano JE, et al. Among authors: borgen pi. Ann Surg Oncol. 1997 Jul-Aug;4(5):416-20. doi: 10.1007/BF02305555. Ann Surg Oncol. 1997. PMID: 9259969

2

Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy.

Osborne MP, Borgen PI, Wong GY, Rosen PP, McCormick B. Osborne MP, et al. Among authors: borgen pi. Surg Gynecol Obstet. 1992 Mar;174(3):189-94. Surg Gynecol Obstet. 1992. PMID: 1542833

3

Bilateral breast cancer.

Fracchia AA, Borgen PI. Fracchia AA, et al. Among authors: borgen pi. Semin Surg Oncol. 1991 Sep-Oct;7(5):300-5. doi: 10.1002/ssu.2980070513. Semin Surg Oncol. 1991. PMID: 1775816 Review.

4

Male breast cancer.

Borgen PI. Borgen PI. Semin Surg Oncol. 1991 Sep-Oct;7(5):314-9. doi: 10.1002/ssu.2980070516. Semin Surg Oncol. 1991. PMID: 1775819 Review.

5

Improved survival in young women with breast cancer.

Anderson BO, Senie RT, Vetto JT, Wong GY, McCormick B, Borgen PI. Anderson BO, et al. Among authors: borgen pi. Ann Surg Oncol. 1995 Sep;2(5):407-15. doi: 10.1007/BF02306373. Ann Surg Oncol. 1995. PMID: 7496835

6

Microdissection and molecular genetic analysis of HER2/neu in breast carcinoma.

Youngson BJ, Anelli A, Van Zee KJ, Borgen PI, Norton L, Rosen PP. Youngson BJ, et al. Among authors: borgen pi. Am J Surg Pathol. 1995 Dec;19(12):1354-8. doi: 10.1097/00000478-199512000-00002. Am J Surg Pathol. 1995. PMID: 7503357

7

p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis.

Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L. Rosen PP, et al. J Clin Oncol. 1995 Apr;13(4):821-30. doi: 10.1200/JCO.1995.13.4.821. J Clin Oncol. 1995. PMID: 7707107

8

Mutations of the p53 gene in male breast cancer.

Anelli A, Anelli TF, Youngson B, Rosen PP, Borgen PI. Anelli A, et al. Among authors: borgen pi. Cancer. 1995 May 1;75(9):2233-8. doi: 10.1002/1097-0142(19950501)75:9<2233::aid-cncr2820750907>3.0.co;2-s. Cancer. 1995. PMID: 7712430

9

Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.

Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P, Norton L. Rosen PP, et al. Cancer. 1995 Mar 15;75(6):1320-6. doi: 10.1002/1097-0142(19950315)75:6<1320::aid-cncr2820750614>3.0.co;2-c. Cancer. 1995. PMID: 7882282

10

Analysis of MTS1/CDK4 in female breast carcinomas.

Rush EB, Abouezzi Z, Borgen PI, Anelli A. Rush EB, et al. Among authors: borgen pi. Cancer Lett. 1995 Mar 2;89(2):223-6. doi: 10.1016/0304-3835(95)03691-o. Cancer Lett. 1995. PMID: 7889533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters